Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Iterum Therapeutics stock

Learn how to easily invest in Iterum Therapeutics stock.

Iterum Therapeutics is a biotechnology business based in the US. Iterum Therapeutics shares (ITRM) are listed on the NASDAQ and all prices are listed in US Dollars. Iterum Therapeutics employs 14 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Iterum Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ITRM. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Iterum Therapeutics stock price (NASDAQ: ITRM)

Use our graph to track the performance of ITRM stocks over time.

Iterum Therapeutics shares at a glance

Information last updated 2023-03-24.
Latest market close$0.97
52-week range$0.60 - $7.02
50-day moving average $1.20
200-day moving average $2.02
Wall St. target price$1.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.66

Buy Iterum Therapeutics stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $10,000 - $250,000+
Stocks, Bonds, Options, Mutual funds, ETFs, Futures
Get up to $600 or more
when you open and fund a new account.
E*TRADE offers commission-free stocks, access to mutual funds and advanced trading tools. Other fees apply.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Iterum Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Iterum Therapeutics price performance over time

Historical closes compared with the close of $0.97 from 2023-03-29

1 week (2023-03-24) 1.06%
1 month (2023-03-03) -20.49%
3 months (2022-12-30) 15.48%
6 months (2022-09-30) -40.12%
1 year (2022-03-29) 155.26%
2 years (2021-03-31) -31.21%
3 years (2020-03-31) 2.71
5 years (2018-03-27) N/A

Iterum Therapeutics financials

Gross profit TTM $37,000
Return on assets TTM -23.99%
Return on equity TTM -113.59%
Profit margin 0%
Book value $2.22
Market capitalisation $12.6 million

TTM: trailing 12 months

Iterum Therapeutics share dividends

We're not expecting Iterum Therapeutics to pay a dividend over the next 12 months.

Have Iterum Therapeutics's shares ever split?

Iterum Therapeutics's shares were split on a 1:15 basis on 17 August 2022. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Iterum Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Iterum Therapeutics shares which in turn could have impacted Iterum Therapeutics's share price.

Iterum Therapeutics share price volatility

Over the last 12 months, Iterum Therapeutics's shares have ranged in value from as little as $0.601 up to $7.017. A popular way to gauge a stock's volatility is its "beta".

ITRM.US volatility(beta: 1.63)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Iterum Therapeutics's is 1.6257. This would suggest that Iterum Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Iterum Therapeutics overview

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland. .

Frequently asked questions

What percentage of Iterum Therapeutics is owned by insiders or institutions?
Currently 1.026% of Iterum Therapeutics shares are held by insiders and 2.279% by institutions.
How many people work for Iterum Therapeutics?
Latest data suggests 14 work at Iterum Therapeutics.
When does the fiscal year end for Iterum Therapeutics?
Iterum Therapeutics's fiscal year ends in December.
Where is Iterum Therapeutics based?
Iterum Therapeutics's address is: Fitzwilliam Court, Dublin, Ireland, 2
What is Iterum Therapeutics's ISIN number?
Iterum Therapeutics's international securities identification number is: IE00BF3W0Q35
What is Iterum Therapeutics's CUSIP number?
Iterum Therapeutics's Committee on Uniform Securities Identification Procedures number is: G6333L101

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site